HCPLive

Internal Medicine
The MD Magazine Internal Medicine specialty page provides clinical news and articles, coverage from conferences and meetings, links to condition-specific resources, and videos and other content.

Conditions

Conferences

Latest CME

Latest Headlines

Study Examines Factors in the Development of HIV-Controlling Antibodies
The study identified several characteristics to observe in HIV patients who develop broadly neutralizing HIV antibodies (bnAbs), which occur naturally in about one percent of those infected with the disease and could be key in an eventual vaccine. Black patients were found more likely to develop them than white.
There are many factors to consider when looking at the most effective treatment methods for multiple sclerosis. A new area researchers are looking at is ways to prevent brain volume loss beyond what most people experience over the course of their lives.
In six years since fingolimod was approved for the treatment of relapsing remitting multiple sclerosis a considerable amount of data has been collected about the oral medication.
There have been great strides made in recent years to help treat patients diagnosed with heart disease. As technology improves and new medications are developed it will be important to ensure they can get to the patients who need them most.
While lifestyle modifications and changes in diet can help prevent heart disease in men and women alike there are some distinct differences when it comes to treating these patients once a diagnosis is made.
As more has been learned over the years about heart disease there is also a greater awareness of the impact it can have on women. Because of this increased awareness a greater effort is underway to help catch these conditions before they become fatal.
The drug, a fully human monoclonal antibody that has impressed equally in asthma and atopic dermatitis trials, may be approved for market as soon as March of 2017.
The FDA has granted approval for ustekinumab (Stelara/Janssen Biotech) to treat adults with moderately-to severely active Crohn’s disease (CD).

Most Popular in Internal Medicine

Recent Published Journal

@MDMagazine

$vacMongoViewPlus$ $vAR$